No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Tuesday's Intraday Session
KALA BIO Advances Eye Disease Therapies With New Funding
KALA BIO | 10-K: FY2024 Annual Report
KALA BIO Cash Resources of $51.2M as of Dec 31 Expected to Fund Ops Into 1Q 2026 >KALA
KALA BIO | 8-K: KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Press Release: KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update